ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cancer quest: Can we drive down the cost of promising … – Genetic Literacy Project

Genetic Literacy ProjectCancer quest: Can we drive down the cost of promising …Genetic Literacy ProjectThe so-called fourth pillar of cancer therapy still has a major drawback – high cost that make gold appear cheap by comparison. Researchers are loo… Continue reading

2017-06-20 Michael Zand NEWS

Determination of Viability and Cell Count of T Cells – AZoM

Determination of Viability and Cell Count of T CellsAZoMIn adoptive CAR-T cell therapy, peripheral blood mononuclear cells (PBMC) are taken from the patient and then engineered CAR-T cells are formed by enrichment of the T cell subset of …and mo… Continue reading

2017-06-20 Michael Zand NEWS

Guide to Determining Viability and Concentration of Stem Cells Grown on Microcarriers – AZoM

AZoMGuide to Determining Viability and Concentration of Stem Cells Grown on MicrocarriersAZoMStem cell research and the significant potentials in stem cell therapy show a great deal of promise in 21st century medical treatments. Since stem cells typica… Continue reading

2017-06-20 Michael Zand NEWS

VIDEO: Pembrolizumab may improve response to CAR T-cell therapy in children with ALL – Healio

Continue reading

2017-06-20 Michael Zand NEWS

Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult – Business Wire (press release)

Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy CatapultBusiness Wire (press release)LONDON–(BUSINESS WIRE)–Cell Medica today announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Ca… Continue reading

2017-06-20 Michael Zand NEWS

Scientists Find New Biomarker to Guide Cancer Immunotherapy – Voice of America

Voice of AmericaScientists Find New Biomarker to Guide Cancer ImmunotherapyVoice of AmericaScientists said on Monday they had pinpointed a particular type of immune system cell that could predict more precisely if cancer patients are likely to respond … Continue reading

2017-06-20 Michael Zand NEWS

Nanoparticle–allergen complexes for allergen immunotherapy – Dove Medical Press


Healio

VIDEO: Pembrolizumab may improve response to CAR T-cell therapy in children with ALL
Healio
CHICAGO — The combination of pembrolizumab and CAR T-cell therapy appeared safe and effective in a subset of patients with acute lymphoblastic leukemia who did not respond to CAR T-cell therapy or who relapsed due to poor CAR T-cell expansion and …

Continue reading

2017-06-20 Michael Zand NEWS

New Cancer Treatment Uses Patient’s Immune System To Fight Disease – CBS Pittsburgh / KDKA

Nanoparticle–allergen complexes for allergen immunotherapy
Dove Medical Press
Abstract: Allergen-specific immunotherapy was introduced in clinical settings more than 100 years ago. It remains the only curative approach to treating allergic disorders that ameliorates symptoms, reduces medication costs, and blocks the onset of new …

and more »

Continue reading

2017-06-20 Michael Zand NEWS
  • 1
  • …
  • 1,598
  • 1,599
  • 1,600
  • 1,601
  • 1,602
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

CBS Pittsburgh / KDKA

New Cancer Treatment Uses Patient’s Immune System To Fight Disease
CBS Pittsburgh / KDKA
Those T-cells then go to a specific place where they are manufactured; reprogrammed to actually be able to attack cancer cells,” Dr. Grupp said. These suped-up cells, now called CAR–T cells are then put back in the body where they multiply and get to work.